Troglitazone: current therapeutic role in type 2 diabetes mellitus.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Z T Bloomgarden

Abstract

To describe the role of troglitazone in the treatment of non-insulin-dependent diabetes mellitus. The potential mechanisms of action of the thiazolidinediones are outlined, and studies that have been conducted in animals and in humans are reviewed. Although the precise mode of action of troglitazone, a thiazolidinedione, is unknown, this agent is an insulin sensitizer that has been shown to decrease fasting insulin, fasting plasma glucose, and blood pressure levels in humans. The effect of troglitazone is progressively greater over time; in several studies, the maximal action occurred as long as 12 weeks after initiation of treatment. The usual daily dose is 200 to 600 mg, and no dosage adjustment is necessary in patients with renal insufficiency. Adverse events, including fluid retention and hepatic dysfunction, may limit the utility of troglitazone in some clinical situations. Both in monotherapy and in combination with sulfonylureas, insulin, or metformin, troglitazone has proved to be an effective agent for the treatment of type 2 diabetes mellitus.

References

Aug 1, 1992·Diabetes Care·C A Hofmann, J R Colca
Nov 24, 1995·The Journal of Biological Chemistry·L TeboulP A Grimaldi
Sep 1, 1995·Metabolism: Clinical and Experimental·M K Lee, J M Olefsky
Apr 1, 1995·Metabolism: Clinical and Experimental·T FujiwaraH Horikoshi
Nov 3, 1994·The New England Journal of Medicine·J J NolanJ Olefsky
Aug 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·K MimuraH Nawata
Jan 1, 1993·Metabolism: Clinical and Experimental·S YoshiokaH Horikoshi
Oct 1, 1995·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·N YagiG Mimura
Jun 1, 1996·The Journal of Clinical Investigation·A Vidal-PuigD E Moller
Sep 1, 1996·Metabolism: Clinical and Experimental·M ShimabukuroN Takasu
Jun 1, 1996·Atherosclerosis·N NoguchiT Kodama
Sep 1, 1996·The American Journal of Physiology·H J HäuselmannE J Thonar
Oct 10, 1996·European Journal of Pharmacology·K LeeP R Boden

❮ Previous
Next ❯

Citations

Oct 10, 2006·Archives of Pharmacal Research·Yoko Shoji, Hideki Nakashima

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.